BR9609196A - Uso de derivados de fenóxi piridina para o tratamento de doenças causadas por distúrbios do sistema de dopamina - Google Patents

Uso de derivados de fenóxi piridina para o tratamento de doenças causadas por distúrbios do sistema de dopamina

Info

Publication number
BR9609196A
BR9609196A BR9609196A BR9609196A BR9609196A BR 9609196 A BR9609196 A BR 9609196A BR 9609196 A BR9609196 A BR 9609196A BR 9609196 A BR9609196 A BR 9609196A BR 9609196 A BR9609196 A BR 9609196A
Authority
BR
Brazil
Prior art keywords
alkyl
carbonyl
amino
hydrogen
disorders
Prior art date
Application number
BR9609196A
Other languages
English (en)
Inventor
Thierry Godel
Deborah Hartman
Claus Riemer
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BR9609196A publication Critical patent/BR9609196A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR9609196A 1995-06-09 1996-06-04 Uso de derivados de fenóxi piridina para o tratamento de doenças causadas por distúrbios do sistema de dopamina BR9609196A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH170495 1995-06-09
PCT/EP1996/002430 WO1996041629A1 (en) 1995-06-09 1996-06-04 Use of phenoxy pyridine derivatives for the treatment of illnesses caused by disorders of the dopamine system

Publications (1)

Publication Number Publication Date
BR9609196A true BR9609196A (pt) 1999-05-11

Family

ID=4216657

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9609196A BR9609196A (pt) 1995-06-09 1996-06-04 Uso de derivados de fenóxi piridina para o tratamento de doenças causadas por distúrbios do sistema de dopamina

Country Status (14)

Country Link
US (1) US5698565A (pt)
EP (1) EP0837680B1 (pt)
JP (1) JP3004732B2 (pt)
AT (1) ATE198984T1 (pt)
AU (1) AU6300396A (pt)
BR (1) BR9609196A (pt)
CA (1) CA2222226A1 (pt)
DE (1) DE69611727T2 (pt)
DK (1) DK0837680T3 (pt)
ES (1) ES2154828T3 (pt)
GR (1) GR3035703T3 (pt)
PT (1) PT837680E (pt)
TR (1) TR199701577T1 (pt)
WO (1) WO1996041629A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997032581A1 (en) * 1996-03-08 1997-09-12 F. Hoffmann-La Roche Ag Use of 4-phenyl-3,6-dihydro-2h-pyridyl derivatives as nmda receptor subtype blockers

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH474511A (pt) * 1966-06-24 1969-06-30 F. Hoffmann-La Roche & Co. Aktiengesellschaft
US3816434A (en) * 1966-06-24 1974-06-11 Hoffmann La Roche 4-(3-(4-phenyl-piperidino)-2-hydroxy-propoxy)-benzophenones
NL133317C (pt) * 1966-06-24 1900-01-01
CH507239A (de) * 1968-12-24 1971-05-15 Hoffmann La Roche Verfahren zur Herstellung von aromatischen Äthern
CH558354A (de) * 1970-06-17 1975-01-31 Hoffmann La Roche Verfahren zur herstellung von aromatischen aethern.
JPS57145872A (en) * 1981-03-05 1982-09-09 Otsuka Pharmaceut Co Ltd Carbostyrile derivative
FR2662355B1 (fr) * 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
HU211019B (en) * 1991-12-02 1995-09-28 Richter Gedeon Vegyeszet Process for producing new 1,2,3,6-tetrahydropyridine and piperidine derivatives substituted with n-(hydroxylalkyl) group and compositions comprising such compounds

Also Published As

Publication number Publication date
TR199701577T1 (xx) 1998-06-22
JP3004732B2 (ja) 2000-01-31
JPH10506651A (ja) 1998-06-30
GR3035703T3 (en) 2001-07-31
DK0837680T3 (da) 2001-05-07
ES2154828T3 (es) 2001-04-16
DE69611727D1 (de) 2001-03-08
CA2222226A1 (en) 1996-12-27
MX9709393A (es) 1998-07-31
WO1996041629A1 (en) 1996-12-27
US5698565A (en) 1997-12-16
AU6300396A (en) 1997-01-09
DE69611727T2 (de) 2001-08-23
EP0837680B1 (en) 2001-01-31
EP0837680A1 (en) 1998-04-29
ATE198984T1 (de) 2001-02-15
PT837680E (pt) 2001-07-31

Similar Documents

Publication Publication Date Title
KR960700707A (ko) 맥관형성 억제제로서 유용한, 생물학적 활성의 3-치환된 옥신돌 유도체(Biologically active 3-substituted oxindole derivatives useful as anti-angiogenic agents)
FI953467A (fi) Aminohappojohdannaisia, näitä yhdisteitä sisältävät lääkeaineet ja menetelmä niiden valmistamiseksi
GEP20022676B (en) 4-Phenyl-Pyridine Derivatives, Method for Their Production and Their Use for Treatment of Disorders Caused by Antagonist of NK-1 Receptors
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
NO305656B1 (no) Nye dihydropyridinforbindelser, farmas°ytiske preparater inneholdende slike forbindelser samt anvendelse av forbindelsene
BR9507073A (pt) Composto processos para preparar o mesmo e para tratar uma doença no sistema nervoso central composiçao farmacêutica e uso do composto
BR9508295A (pt) Utilização de compostos de tiazol e tiadiazol composto composição farmacêutica e processos para preparar um composto e tratar distúrbios que respondem a ligantes de receptor d3 de dopamina
MX9300552A (es) Derivados de etanolamina
DK0960111T3 (da) Morphinderivat med analgesisk aktivitet
AU2342397A (en) N-aminoalkyldibenzothiophenecarboxamides; dopamine receptor subtype specific ligands
FI945581A0 (fi) Substituoidut (aryylialkoksibentsyyli) aminopropaaniamidijohdannaiset, niiden valmistus ja käyttö antiepileptisinä, neuroprotektiivisina ja antidepressiivisinä aineina
ES512574A0 (es) "procedimiento de preparacion de derivados carboxilato".
NO308658B1 (no) Sammenføyde isoquinoliner som dopamin-reseptor-ligander
FI945582A0 (fi) Substituoidut (aryylialkyyliaminobentsyyli) aminopropioniamidijohdannaiset, niiden valmistus ja käyttö anti-epileptisinä, neuroprotektiivisina ja antidepressiivisina aineina
BR9609196A (pt) Uso de derivados de fenóxi piridina para o tratamento de doenças causadas por distúrbios do sistema de dopamina
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
PT1082116E (pt) Utilizacao de derivados de 4-piperidinometanol no tratamento de desordens do neurodesenvolvimento
RU2221786C2 (ru) Производные тетрагидроизохинолиналканола, способы лечения и фармацевтические композиции на их основе
RU95121739A (ru) Применение производных 3-замещенного оксиндола в качестве анти-ангиогенных агентов, фармацевтическая композиция и способ лечения

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal